Toll-like receptor 3/TRIF-dependent IL-12p70 secretion mediated by Streptococcus pneumoniae RNA and its priming by influenza a virus coinfection in human dendritic cells

mBio

Volumn 7, Issue 2, 2016, Pages

  Spelmink, Laura ^a   Sender, Vicky ^a   Hentrich, Karina ^a   Kuri, Thomas ^a   Plant, Laura ^a   Henriques Normarka, Birgitta ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; DOUBLE STRANDED RNA; INTERLEUKIN 12P70; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; CYTOKINE; INTERLEUKIN 12; TICAM1 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOSOME; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA A VIRUS; INTERNALIZATION; INTRACELLULAR SIGNALING; MIXED INFECTION; MONOCYTE; NONHUMAN; NORMAL HUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; GENETICS; IMMUNOLOGY; INFLUENZA; MICROBIOLOGY; PHYSIOLOGY; VIROLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; COINFECTION; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERLEUKIN-12; MONOCYTES; PNEUMOCOCCAL INFECTIONS; RNA, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 3;

EID: 84965118332     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00168-16     Document Type: Article

References (62)

1. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893–902.http://dx.doi.org/10.1016/S0140-6736(09)61204-6.
2. Janssens J-P, Krause K-H. 2004. Pneumonia in the very old. Lancet Infect Dis 4:112–124.http://dx.doi.org/10.1016/S1473-3099(04)00931-4.
3. Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. 2000. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J 19:1141–1147.http://dx.doi.org/10.1097/00006454-200012000-00004.
4. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. 2010. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 202:1287–1295.http://dx.doi.org/10.1086/656333.
5. Klugman KP, Madhi SA. 2007. Pneumococcal vaccines and flu preparedness. Science 316:49–50.http://dx.doi.org/10.1126/science.316.5821.49c.
6. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:962–970.http://dx.doi.org/10.1086/591708.
7. Tasher D, Stein M, Simões EA, Shohat T, Bromberg M, Somekh E. 2011. Invasive bacterial infections in relation to influenza outbreaks, 2006–2010. Clin Infect Dis 53:1199–1207.http://dx.doi.org/10.1093/cid/cir726.
8. Koppe U, Suttorp N, Opitz B. 2012. Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 14:460–466.http://dx.doi.org/10.1111/j.1462-5822.2011.01746.x.
9. Opitz B, Püschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, Hippenstiel S. 2004. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279:36426–36432.http://dx.doi.org/10.1074/jbc.M403861200.
10. Davis KM, Nakamura S, Weiser JN. 2011. Nod2 sensing of lysozymedigested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121:3666–3676.http://dx.doi.org/10.1172/JCI57761.
11. Schröder NW, Morath S, Alexander C, Hamann L, Hartung T, Zähringer U, Göbel UB, Weber JR, Schumann RR. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharidebinding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278:15587–15594.http://dx.doi.org/10.1074/jbc.M212829200.
12. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100:1966–1971.http://dx.doi.org/10.1073/pnas.0435928100.
13. Bernatoniene J, Zhang Q, Dogan S, Mitchell TJ, Paton JC, Finn A. 2008. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by Toll-like receptor 4, NF-kappa B, and mitogen-activated protein kinases. J Infect Dis 198:1823–1833.http://dx.doi.org/10.1086/593177.
14. Shoma S, Tsuchiya K, Kawamura I, Nomura T, Hara H, Uchiyama R, Daim S, Mitsuyama M. 2008. Critical involvement of pneumolysin in production of interleukin-1 alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation. Infect Immun 76:1547–1557.http://dx.doi.org/10.1128/IAI.01269-07.
15. Schmeck B, Moog K, Zahlten J, van Laak V, N’Guessan PD, Opitz B, Rosseau S, Suttorp N, Hippenstiel S. 2006. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res 7:98.http://dx.doi.org/10.1186/1465-9921-7-98.
16. Srivastava A, Henneke P, Visintin A, Morse SC, Martin V, Watkins C, Paton JC, Wessels MR, Golenbock DT, Malley R. 2005. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 73:6479–6487.http://dx.doi.org/10.1128/IAI.73.10.6479-6487.2005.
17. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B. 2007. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 9:633–644.http://dx.doi.org/10.1111/j.1462-5822.2006.00814.x.
18. Albiger B, Sandgren A, Katsuragi H, Meyer-Hoffert U, Beiter K, Wartha F, Hornef M, Normark S, Normark BH. 2005. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol 7:1603–1615.http://dx.doi.org/10.1111/j.1462-5822.2005.00578.x.
19. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. 2002. Cutting edge: a novel toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169:6668–6672.http://dx.doi.org/10.4049/jimmunol.169.12.6668.
20. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640–643.http://dx.doi.org/10.1126/science.1087262.
21. Yamamoto N, Kawakami K, Kinjo Y, Miyagi K, Kinjo T, Uezu K, Nakasone C, Nakamatsu M, Saito A. 2004. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma. Microbes Infect 6:1241–1249.http://dx.doi.org/10.1016/j.micinf.2004.08.007.
22. Kemp K, Bruunsgaard H, Skinhøj P, Klarlund Pedersen B. 2002. Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect Immun 70: 5019–5025.http://dx.doi.org/10.1128/IAI.70.9.5019-5025.2002.
23. Rubins JB, Pomeroy C. 1997. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 65: 2975–2977.
24. Sun K, Salmon SL, Lotz SA, Metzger DW. 2007. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun 75:1196–1202.http://dx.doi.org/10.1128/IAI.01403-06.
25. Haraguchi S, Day NK, Nelson RP, Emmanuel P, Duplantier JE, Christodoulou CS, Good RA. 1998. Interleukin 12 deficiency associated with recurrent infections. Proc Natl Acad Sci U S A 95:13125–13129.http://dx.doi.org/10.1073/pnas.95.22.13125.
26. McCullers JA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571–582.http://dx.doi.org/10.1128/CMR.00058-05.
27. Jamieson AM, Yu S, Annicelli CH, Medzhitov R. 2010. Influenza virusinduced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7:103–114.http://dx.doi.org/10.1016/j.chom.2010.01.010.
28. Van der Sluijs KF, van Elden LJR, Nijhuis M, Schuurman R, Pater JM, Florquin S, Goldman M, Jansen HM, Lutter R, van der Poll T. 2004. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172:7603–7609.http://dx.doi.org/10.4049/jimmunol.172.12.7603.
29. Zavitz CC, Bauer CM, Gaschler GJ, Fraser KM, Strieter RM, Hogaboam CM, Stampfli MR. 2010. Dysregulated macrophageinflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol 184:2001–2013.http://dx.doi.org/10.4049/jimmunol.0903304.
30. McCullers JA, Rehg JE. 2002. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 186:341–350.http://dx.doi.org/10.1086/341462.
31. McCullers JA, Bartmess KC. 2003. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 187:1000–1009.http://dx.doi.org/10.1086/368163.
32. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan J-C, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C, Gonzalez I, Torner N, Banner D, Leon A, Cuesta P, Rowe T, Kelvin DJ. 2009. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13:R201.http://dx.doi.org/10.1186/cc8208.
33. Kuri T, Sörensen AS, Thomas S, Karlsson Hedestam GB, Normark S, Henriques-Normark B, McInerney GM, Plant L. 2013. Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae. Cell Microbiol 15: 1385–1400.http://dx.doi.org/10.1111/cmi.12122.
34. Wu Y, Mao H, Ling M-T, Chow K-H, Ho P-L, Tu W, Lau Y-L. 2011. Successive influenza virus infection and Streptococcus pneumoniae stimulation alter human dendritic cell function. BMCInfect Dis 11:201.http://dx.doi.org/10.1186/1471-2334-11-201.
35. Littmann M, Albiger B, Frentzen A, Normark S, Henriques-Normark B, Plant L. 2009. Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med 1:211–222.http://dx.doi.org/10.1002/emmm.200900025.
36. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Müller M, Blander JM. 2011. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474: 385–389.http://dx.doi.org/10.1038/nature10072.
37. Eberle F, Sirin M, Binder M, Dalpke AH. 2009. Bacterial RNA is recognized by different sets of immunoreceptors. Eur J Immunol 39: 2537–2547.http://dx.doi.org/10.1002/eji.200838978.
38. Inoue R, Nagino T, Hoshino G, Ushida K. 2011. Nucleic acids of Enterococcus faecalis strain EC-12 are potent Toll-like receptor 7 and 9 ligands inducing interleukin-12 production from murine splenocytes and murine macrophage cell line J774.1. FEMS Immunol Med Microbiol 61: 94–102.http://dx.doi.org/10.1111/j.1574-695X.2010.00752.x.
39. Gratz N, Hartweger H, Matt U, Kratochvill F, Janos M, Sigel S, Drobits B, Li X-D, Knapp S, Kovarik P. 2011. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog 7:e1001345.http://dx.doi.org/10.1371/journal.ppat.1001345.
40. Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P. 2011. Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep 12:71–76.http://dx.doi.org/10.1038/embor.2010.189.
41. Eigenbrod T, Franchi L, Muñoz-Planillo R, Kirschning CJ, Freudenberg MA, Núñez G, Dalpke A. 2012. Bacterial RNA mediates activation of caspase-1 and IL-1 beta release independently of TLRs 3, 7, 9 and TRIF but is dependent on UNC93B. J Immunol 189:328–336.http://dx.doi.org/10.4049/jimmunol.1103258.
42. Hidmark A, von Saint Paul A, Dalpke AH. 2012. Cutting edge: TLR13 is a receptor for bacterial RNA. J Immunol 189:2717–2721.http://dx.doi.org/10.4049/jimmunol.1200898.
43. Kawashima T, Kosaka A, Yan H, Guo Z, Uchiyama R, Fukui R, Kaneko D, Kumagai Y, You D-J, Carreras J, Uematsu S, Jang MH, Takeuchi O, Kaisho T, Akira S, Miyake K, Tsutsui H, Saito T, Nishimura I, Tsuji NM. 2013. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-beta. Immunity 38:1187–1197.http://dx.doi.org/10.1016/j.immuni.2013.02.024.
44. Bai W, Liu H, Ji Q, Zhou Y, Liang L, Zheng R, Chen J, Liu Z, Yang H, Zhang P, Kaufmann SH, Ge B. 2014. TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. Cell Signal 26:942–950.http://dx.doi.org/10.1016/j.cellsig.2014.01.015.
45. Hovden A-O, Karlsen M, Jonsson R, Appel S. 2012. The bacterial preparation OK432 induces IL-12p70 secretion in human dendritic cells in a TLR3 dependent manner. PLoS One 7:e31217.http://dx.doi.org/10.1371/journal.pone.0031217.
46. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL, Weiser JN. 2006. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 281:12994–12998.http://dx.doi.org/10.1074/jbc.M511431200.
47. Koga T, Lim JH, Jono H, Ha UH, Xu H, Ishinaga H, Morino S, Xu X, Yan C, Kai H, Li J-D. 2008. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling. J Biol Chem 283:12546-12554.http://dx.doi.org/10.1074/jbc.M710518200.
48. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Pétrilli V, Andrew PW, Kadioglu A, Lavelle EC. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6:e1001191.http://dx.doi.org/10.1371/journal.ppat.1001191.
49. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T. 2004. Role of Toll-like receptor 4 in grampositive and gram-negative pneumonia in mice. Infect Immun 72: 788–794.http://dx.doi.org/10.1128/IAI.72.2.788-794.2004.
50. Knapp S, Wieland CW, van’t Veer C, Takeuchi O, Akira S, Florquin S, van der Poll T. 2004. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 172:3132–3138.http://dx.doi.org/10.4049/jimmunol.172.5.3132.
51. Schreibelt G, Tel J, Sliepen KH, Benitez-Ribas D, Figdor CG, Adema GJ, de Vries IJ. 2010. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol Immunother 59:1573–1582.http://dx.doi.org/10.1007/s00262-010-0833-1.
52. Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Müller M, Krause SW, Rehli M. 2003. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 278:21502–21509.http://dx.doi.org/10.1074/jbc.M301476200.
53. Tanabe M, Kurita-Taniguchi M, Takeuchi K, Takeda M, Ayata M, Ogura H, Matsumoto M, Seya T. 2003. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virusattenuated strains. Biochem Biophys Res Commun 311:39–48.http://dx.doi.org/10.1016/j.bbrc.2003.09.159.
54. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M. 2006. Detrimental contribution of the Tolllike receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2:e53.http://dx.doi.org/10.1371/journal.ppat.0020053.
55. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280:5571–5580.http://dx.doi.org/10.1074/jbc.M410592200.
56. Tian X, Xu F, Lung WY, Meyerson C, Ghaffari AA, Cheng G, Deng JC. 2012. PolyI:C enhances susceptibility to secondary pulmonary infections by Gram-positive bacteria. PLoS One 7:e41879.http://dx.doi.org/10.1371/journal.pone.0041879.
57. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506.http://dx.doi.org/10.1126/science.1061217.
58. Fernebro J, Andersson I, Sublett J, Morfeldt E, Novak R, Tuomanen E, Normark S, Normark BH. 2004. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance. J Infect Dis 189:328–338.http://dx.doi.org/10.1086/380564.
59. Kilbourne ED. 1969. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 41:643–645.
60. Matrosovich M, Matrosovich T, Garten W, Klenk H-D. 2006. New low-viscosity overlay medium for viral plaque assays. Virol J 3:63.http://dx.doi.org/10.1186/1743-422X-3-63.
61. Rossi O, Pesce I, Giannelli C, Aprea S, Caboni M, Citiulo F, Valentini S, Ferlenghi I, MacLennan CA, D’Oro U, Saul A, Gerke C. 2014. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants. J Biol Chem 289: 24922–24935.http://dx.doi.org/10.1074/jbc.M114.566570.
62. Seubert A, Calabro S, Santini L, Galli B, Genovese A, Valentini S, Aprea S, Colaprico A, D’Oro U, Giuliani MM, Pallaoro M, Pizza M, O’Hagan DT, Wack A, Rappuoli R, De Gregorio E. 2011. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. Proc Natl Acad Sci U S A 108: 11169–11174.http://dx.doi.org/10.1073/pnas.1107941108.